Porton Pharma Solutions Ltd. is attending the 23rd International Symposium on Industrial Crystallization from September 6 to 9.

With over 4,300 employees and 17 operations and commercial offices across the globe, Porton Pharma Solutions provides global pharmaceutical and biotech companies with innovative, reliable, and end-to-end process R&D and GMP manufacturing services across Small Molecules, Tides, Biologics and Conjugates (ADCs, AOCs, PDCs, RDCs, etc.), as well as Advanced Therapy Medicinal Products. We are committed to a customer-centric approach and have been recognized through awards by industry forums and global pharmaceutical and biotech companies for our process innovation, supply chain performance, and compliance with global quality and EHS standards. We constantly strive for excellence and work to enable earlier access to good medicines.